Literature DB >> 16926346

Report criticizes lack of FDA oversight.

Mike Mitka.   

Abstract

Mesh：

Year:  2006        PMID： 16926346     DOI： 10.1001/jama.296.8.920

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

1.  Preemption, tort reform, and pharmaceutical claims: Part two: Has the Food and Drug Administration shown it is solely responsible for the protection of patients? Can it do so? Will it do so?

Authors:  Russell G Thornton
Journal:  Proc (Bayl Univ Med Cent)       Date:  2008-01

Review 2.  Pharmacovigilance: methods, recent developments and future perspectives.

Authors:  L Härmark; A C van Grootheest
Journal:  Eur J Clin Pharmacol       Date:  2008-06-04       Impact factor: 2.953

3.  Changes in FDA enforcement activities following changes in federal administration: the case of regulatory letters released to pharmaceutical companies.

Authors:  Diane Nguyen; Enrique Seoane-Vazquez; Rosa Rodriguez-Monguio; Michael Montagne
Journal:  BMC Health Serv Res       Date:  2013-01-22       Impact factor: 2.655
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.